作者: Hans Jürgen Dornbusch , Timo Vesikari , Alfredo Guarino , Andrea LoVecchio , Adamos Hadjipanayis
DOI: 10.1007/S00431-020-03608-5
关键词:
摘要: Rotavirus gastroenteritis affects all children. Studies indicate that by the age of 5 years, almost children have developed rotavirus antibodies. It has been estimated in Europe, approximately 6550 each year die as a result infection. Most this mortality does not affect from identifiable risk groups, but previously healthy infants. There is no accountable evidence on increased severity infection specific including born preterm or immunocompromised Universal immunization areas successfully achieved large coverage greatly improved health children, reducing rates, hospitalization, and costs. Vaccination infants with presumed high may be beneficial for vaccinated individuals, such strategy also cost-effective certain settings. Identifying high-risk within first few weeks life rather difficult especially countries without primary care pediatricians goes along additional Conclusion: vaccines should recommended universal approach restricted to subgroups assumed risk. Targeted vaccination could considered an option limited financial resources.